SCHEMBL102091

SCHEMBL102091

C1C[C]2CCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25391815 1.00
SCHEMBL149012 0.93
SCHEMBL70819 0.90
SCHEMBL295795 0.88
SCHEMBL35115 0.88 KMT2A (0.33)
SCHEMBL7391293 0.88 KMT2A (0.33)
SCHEMBL102511 0.87
SCHEMBL1538419 0.84 KMT2A (0.35)
SCHEMBL1538646 0.84 KMT2A (0.35)
SCHEMBL1089080 0.84 KMT2A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1733 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166645-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2024-05-23 US claimed
WO-2024083223-A1 MACROCYCLIC COMPOUNDS AND MEDICAL USE THEREOF 正大天晴药业集团股份有限公司 2024-04-25 WO claimed
EP-4289843-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2023-12-13 EP claimed
CN-116396278-A Carbazole derivatives as dopamine D3 receptor selectivity modulators 北京大学 2023-07-07 CN claimed
WO-2023078463-A1 AZOBENZENE COMPOUND AND APPLICATION THEREOF 正大天晴药业集团股份有限公司 2023-05-11 WO claimed
CN-113072521-A ROR gamma t inhibitor and application thereof in medicine 广东东阳光药业有限公司 2021-07-06 CN claimed
WO-2014028669-A1 NOVEL COMPOUNDS FOR MODULATION OF ROR-GAMMA ACTIVITY BIOGEN IDEC MA INC. (US) 2014-02-20 WO claimed
US-20130122050-A1 COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE ANALOGS AND ISLET NEOGENESIS ASSOCIATED PEPTIDE DIAKINE THERAPEUTICS, INC. (US) 2013-05-16 US claimed
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-19 US claimed
EP-2456310-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS Vanderbilt University (US) 2012-05-30 EP claimed
EP-1171442-A1 XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALLING INHIBITORS CELL THERAPEUTICS, INC. (US) 2002-01-16 EP claimed
WO-2000061583-A1 XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 2000-10-19 WO claimed
US-6103730-A Amine substituted compounds CELL THERAPEUTICS, INC. (US) 2000-08-15 US claimed
US-6100271-A Therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-08-08 US claimed
US-6043250-A Methods for using therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-03-28 US claimed
EP-0746557-A4 INTRACELLULAR SIGNALLING MEDIATORS CELL THERAPEUTICS INC (US) 1997-05-02 EP claimed
EP-0746557-A1 INTRACELLULAR SIGNALLING MEDIATORS CELL THERAPEUTICS, INC. (US) 1996-12-11 EP claimed
WO-1995022546-A1 INTRACELLULAR SIGNALLING MEDIATORS CELL THERAPEUTICS, INC. (US) 1995-08-24 WO claimed
WO-1995020589-A1 CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1995-08-03 WO claimed
US-5294531-A BicycloUm.n.oealkane-1-ylcarbonylacetamide compound FUJI PHOTO FILM CO., LTD. (JP) 1994-03-15 US claimed